nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—Detoxification of Reactive Oxygen Species—GSR—amyotrophic lateral sclerosis	0.0808	0.164	CbGpPWpGaD
Auranofin—PRDX5—hindbrain—amyotrophic lateral sclerosis	0.0463	0.194	CbGeAlD
Auranofin—PRDX5—Detoxification of Reactive Oxygen Species—SOD1—amyotrophic lateral sclerosis	0.0365	0.074	CbGpPWpGaD
Auranofin—PRDX5—Detoxification of Reactive Oxygen Species—GSTP1—amyotrophic lateral sclerosis	0.0357	0.0722	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.0314	0.0636	CbGpPWpGaD
Auranofin—PRDX5—embryo—amyotrophic lateral sclerosis	0.029	0.121	CbGeAlD
Auranofin—PRDX5—brainstem—amyotrophic lateral sclerosis	0.0265	0.111	CbGeAlD
Auranofin—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0793	CcSEcCtD
Auranofin—PRDX5—medulla oblongata—amyotrophic lateral sclerosis	0.0185	0.0775	CbGeAlD
Auranofin—IKBKB—embryo—amyotrophic lateral sclerosis	0.0171	0.0718	CbGeAlD
Auranofin—PRDX5—spinal cord—amyotrophic lateral sclerosis	0.0165	0.0691	CbGeAlD
Auranofin—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0609	CcSEcCtD
Auranofin—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0549	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.0142	0.0287	CbGpPWpGaD
Auranofin—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0527	CcSEcCtD
Auranofin—PRDX5—nervous system—amyotrophic lateral sclerosis	0.0139	0.0582	CbGeAlD
Auranofin—PRDX5—central nervous system—amyotrophic lateral sclerosis	0.0134	0.056	CbGeAlD
Auranofin—PRDX5—cerebellum—amyotrophic lateral sclerosis	0.0131	0.0548	CbGeAlD
Auranofin—PRDX5—Cellular responses to stress—GSR—amyotrophic lateral sclerosis	0.013	0.0264	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—VCP—amyotrophic lateral sclerosis	0.0126	0.0255	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0432	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0408	CcSEcCtD
Auranofin—PRDX5—brain—amyotrophic lateral sclerosis	0.0106	0.0445	CbGeAlD
Auranofin—IKBKB—p75NTR recruits signalling complexes—SQSTM1—amyotrophic lateral sclerosis	0.0104	0.0211	CbGpPWpGaD
Auranofin—IKBKB—NF-kB is activated and signals survival—SQSTM1—amyotrophic lateral sclerosis	0.0104	0.0211	CbGpPWpGaD
Auranofin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00942	0.0352	CcSEcCtD
Auranofin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00895	0.0335	CcSEcCtD
Auranofin—IKBKB—p75NTR signals via NF-kB—SQSTM1—amyotrophic lateral sclerosis	0.00884	0.0179	CbGpPWpGaD
Auranofin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00881	0.0329	CcSEcCtD
Auranofin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00852	0.0319	CcSEcCtD
Auranofin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00823	0.0308	CcSEcCtD
Auranofin—IKBKB—nervous system—amyotrophic lateral sclerosis	0.00823	0.0345	CbGeAlD
Auranofin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0306	CcSEcCtD
Auranofin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0306	CcSEcCtD
Auranofin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00801	0.03	CcSEcCtD
Auranofin—IKBKB—central nervous system—amyotrophic lateral sclerosis	0.00793	0.0332	CbGeAlD
Auranofin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00784	0.0293	CcSEcCtD
Auranofin—IKBKB—cerebellum—amyotrophic lateral sclerosis	0.00775	0.0324	CbGeAlD
Auranofin—PRDX5—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00718	0.0145	CbGpPWpGaD
Auranofin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00705	0.0264	CcSEcCtD
Auranofin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00666	0.0249	CcSEcCtD
Auranofin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00647	0.0242	CcSEcCtD
Auranofin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00643	0.024	CcSEcCtD
Auranofin—IKBKB—brain—amyotrophic lateral sclerosis	0.00629	0.0264	CbGeAlD
Auranofin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00607	0.0227	CcSEcCtD
Auranofin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.006	0.0224	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.00589	0.0119	CbGpPWpGaD
Auranofin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00588	0.022	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.00575	0.0117	CbGpPWpGaD
Auranofin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00525	0.0196	CcSEcCtD
Auranofin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00511	0.0191	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—RTN4—amyotrophic lateral sclerosis	0.00496	0.01	CbGpPWpGaD
Auranofin—IKBKB—IL1-mediated signaling events—SQSTM1—amyotrophic lateral sclerosis	0.00484	0.00979	CbGpPWpGaD
Auranofin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.0176	CcSEcCtD
Auranofin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0174	CcSEcCtD
Auranofin—IKBKB—NOD1/2 Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.00465	0.00942	CbGpPWpGaD
Auranofin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0171	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.00454	0.0092	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0164	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—RTN4—amyotrophic lateral sclerosis	0.00432	0.00874	CbGpPWpGaD
Auranofin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0159	CcSEcCtD
Auranofin—IKBKB—Interleukin-1 signaling—SQSTM1—amyotrophic lateral sclerosis	0.00425	0.0086	CbGpPWpGaD
Auranofin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0158	CcSEcCtD
Auranofin—IKBKB—Insulin Signaling—PTPRF—amyotrophic lateral sclerosis	0.00417	0.00845	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.00386	0.00782	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —SQSTM1—amyotrophic lateral sclerosis	0.0038	0.00769	CbGpPWpGaD
Auranofin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00379	0.0142	CcSEcCtD
Auranofin—IKBKB—NOD pathway—CASP9—amyotrophic lateral sclerosis	0.00372	0.00753	CbGpPWpGaD
Auranofin—IKBKB—Osteopontin Signaling—MMP9—amyotrophic lateral sclerosis	0.00371	0.00751	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—ATF1—amyotrophic lateral sclerosis	0.00369	0.00747	CbGpPWpGaD
Auranofin—ALB—brain—amyotrophic lateral sclerosis	0.00367	0.0154	CbGeAlD
Auranofin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00367	0.0137	CcSEcCtD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—amyotrophic lateral sclerosis	0.00358	0.00725	CbGpPWpGaD
Auranofin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0127	CcSEcCtD
Auranofin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0126	CcSEcCtD
Auranofin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0126	CcSEcCtD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—SQSTM1—amyotrophic lateral sclerosis	0.00329	0.00667	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00329	0.00667	CbGpPWpGaD
Auranofin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0119	CcSEcCtD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP9—amyotrophic lateral sclerosis	0.00317	0.00643	CbGpPWpGaD
Auranofin—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.00291	0.00589	CbGpPWpGaD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.00282	0.00571	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—SQSTM1—amyotrophic lateral sclerosis	0.00275	0.00556	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.0027	0.00547	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP9—amyotrophic lateral sclerosis	0.00254	0.00515	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—CASP9—amyotrophic lateral sclerosis	0.00251	0.00508	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—CASP9—amyotrophic lateral sclerosis	0.00245	0.00497	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—ATF1—amyotrophic lateral sclerosis	0.00241	0.00488	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—SQSTM1—amyotrophic lateral sclerosis	0.00239	0.00484	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00237	0.00481	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.00235	0.00475	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—SOD1—amyotrophic lateral sclerosis	0.00228	0.00462	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00226	0.00458	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—ATF1—amyotrophic lateral sclerosis	0.00218	0.00441	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—PLA2G4A—amyotrophic lateral sclerosis	0.00218	0.00441	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—amyotrophic lateral sclerosis	0.00216	0.00437	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00214	0.00433	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—ATF1—amyotrophic lateral sclerosis	0.00212	0.00429	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00212	0.00429	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.0021	0.00424	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—BDNF—amyotrophic lateral sclerosis	0.00207	0.00419	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—ATF1—amyotrophic lateral sclerosis	0.00205	0.00414	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00204	0.00414	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.00204	0.00412	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—ATF1—amyotrophic lateral sclerosis	0.00201	0.00407	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP9—amyotrophic lateral sclerosis	0.00197	0.00398	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.00195	0.00394	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00193	0.00391	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—ATF1—amyotrophic lateral sclerosis	0.00193	0.00391	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—SQSTM1—amyotrophic lateral sclerosis	0.00192	0.00388	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—CASP3—amyotrophic lateral sclerosis	0.00178	0.0036	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.00177	0.00359	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—ATF1—amyotrophic lateral sclerosis	0.00174	0.00351	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPT—amyotrophic lateral sclerosis	0.00171	0.00345	CbGpPWpGaD
Auranofin—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00167	0.00338	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—ATF1—amyotrophic lateral sclerosis	0.00163	0.0033	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—IGF1—amyotrophic lateral sclerosis	0.00161	0.00326	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RTN4—amyotrophic lateral sclerosis	0.00159	0.00322	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00157	0.00317	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00154	0.00311	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00152	0.00309	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00148	0.003	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.00145	0.00294	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—MMP9—amyotrophic lateral sclerosis	0.00145	0.00294	CbGpPWpGaD
Auranofin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.0013	0.00264	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00128	0.00259	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CASP9—amyotrophic lateral sclerosis	0.00121	0.00245	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.0012	0.00244	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.0012	0.00244	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	0.00115	0.00234	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00115	0.00232	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.00115	0.00232	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.00115	0.00232	CbGpPWpGaD
Auranofin—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00111	0.00225	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00109	0.00221	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.00107	0.00217	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.00107	0.00216	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00105	0.00213	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.00103	0.0021	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.00103	0.00209	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—CASP3—amyotrophic lateral sclerosis	0.00103	0.00209	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—BDNF—amyotrophic lateral sclerosis	0.00101	0.00205	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.00101	0.00205	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000988	0.002	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000984	0.00199	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000957	0.00194	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000948	0.00192	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00094	0.0019	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000914	0.00185	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—CASP3—amyotrophic lateral sclerosis	0.000899	0.00182	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.000895	0.00181	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000882	0.00179	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.00088	0.00178	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00086	0.00174	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000859	0.00174	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP3—amyotrophic lateral sclerosis	0.000828	0.00168	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000825	0.00167	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00082	0.00166	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0008	0.00162	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000786	0.00159	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000783	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000777	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000755	0.00153	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000752	0.00152	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000731	0.00148	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	0.000678	0.00137	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000678	0.00137	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000673	0.00136	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—amyotrophic lateral sclerosis	0.000662	0.00134	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000651	0.00132	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.00063	0.00128	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.0006	0.00122	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000573	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000566	0.00115	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000543	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—amyotrophic lateral sclerosis	0.000531	0.00107	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000515	0.00104	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000507	0.00103	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000504	0.00102	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000489	0.000989	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000484	0.00098	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000471	0.000953	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000458	0.000928	CbGpPWpGaD
Auranofin—IKBKB—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000458	0.000927	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000448	0.000908	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000437	0.000884	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000431	0.000872	CbGpPWpGaD
Auranofin—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000419	0.000848	CbGpPWpGaD
Auranofin—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000419	0.000848	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000411	0.000833	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000411	0.000832	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000392	0.000794	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00039	0.000791	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000384	0.000777	CbGpPWpGaD
Auranofin—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000383	0.000776	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000371	0.000752	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000371	0.000752	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000369	0.000746	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000363	0.000735	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000363	0.000734	CbGpPWpGaD
Auranofin—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000356	0.000721	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000347	0.000702	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000341	0.000691	CbGpPWpGaD
Auranofin—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000335	0.000678	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000331	0.000671	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000331	0.00067	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000325	0.000658	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000324	0.000655	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000319	0.000646	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000313	0.000635	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000306	0.00062	CbGpPWpGaD
Auranofin—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000303	0.000613	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000292	0.000592	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000279	0.000566	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000278	0.000564	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000275	0.000557	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ATF1—amyotrophic lateral sclerosis	0.000274	0.000555	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP9—amyotrophic lateral sclerosis	0.000261	0.000529	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000236	0.000478	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000229	0.000465	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000224	0.000453	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000212	0.000429	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000212	0.000429	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40LG—amyotrophic lateral sclerosis	0.00021	0.000426	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000193	0.000391	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000189	0.000383	CbGpPWpGaD
Auranofin—IKBKB—Immune System—C3—amyotrophic lateral sclerosis	0.000186	0.000376	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000183	0.00037	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000177	0.000359	CbGpPWpGaD
Auranofin—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000174	0.000352	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000169	0.000342	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000159	0.000321	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000145	0.000293	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000144	0.000292	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000136	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00012	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000112	0.000226	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000109	0.00022	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	9.41e-05	0.000191	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.35e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.24e-05	0.000187	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.59e-05	0.000174	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.11e-05	0.000144	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	7.11e-05	0.000144	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	7.07e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.72e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.03e-05	0.000122	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.84e-05	9.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.56e-05	9.23e-05	CbGpPWpGaD
